相关实验视频
Updated: May 10, 2025

05:17
Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451
Published on: April 18, 2025
58
陶氏PET成像在神经退行现有的作用
Greet Vanderlinden1, Rik Vandenberghe2, Mathieu Vandenbulcke3
1Nuclear Medicine and Molecular Imaging, Department of Imaging and Pathology, Leuven Brain Institute, KU Leuven, Leuven, Belgium.
Seminars in nuclear medicine
|April 22, 2025
概括
本综述涵盖神经退行性病症,重点关注用于诊断和药物开发的PET标记物. 它将PET成像与临床使用的液体生物标志物进行比较.
科学领域:
- 神经学 神经学
- 放射化学 放射化学是指辐射化学.
- 生物标志物开发 生物标志物开发
背景情况:
- 神经退行性病症涉及异常的蛋白酸化和聚合.
- 定子发射断层扫描 (PET) 追踪剂对于追踪疾病进展和帮助药物开发至关重要.
研究的目的:
- 审查tau在神经退行性疾病中的病理生理学.
- 总结当前和新兴的TAU-PET标记剂及其量化.
- 为了比较TAU PET成像与液体生物标志物 (CSF和血) 的临床应用.
主要方法:
- 病理生理学的文献综述.
- 关于第一代和第二代TAU PET标记剂的概述,包括新开发.
- 讨论TAU PET图像的量化和与流体生物标记物的比较.
主要成果:
- 陶氏PET标记剂提供一种非侵入性方法,可以在体内可视化陶氏病理.
- 新的标记剂显示出更好的结合特性和量化潜力.
- 正在确定tau PET与液体生物标志物的相关性和临床效用.
结论:
- 陶氏PET成像是了解陶氏病变和推进治疗方法的宝贵工具.
- 建议将TAU PET和液体生物标志物的整合用于诊断,预后和治疗开发.
相关概念视频
Positron Emission Tomography
3.9K
Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
3.9K
Brain Imaging
193
Brain imaging technologies provide critical insights into both the structure and function of the human brain, enabling medical professionals and researchers to diagnose, study, and treat neurological disorders or psychiatric disorders more effectively.
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic...
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic...
193
Alzheimer's Disease: Overview
317
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
317

![PET Imaging of Neuroinflammation Using [11C]DPA-713 in a Mouse Model of Ischemic Stroke](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F57243.jpg&w=3840&q=50)